Clinical Trial Update: A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma（Keyplus-001） [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for LB1410 in participants with advanced solid tumors or lymphoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• LB1410

Snippet

Sponsor: L & L Bio Co., Ltd., Ningbo, China | Conditions: Solid Tumor, Lymphoma | Phase 1 | Status: RECRUITING